Medical device reporting
This article was originally published in The Gray Sheet
Aug. 27 Federal Register notice withdraws FDA's May 12 direct-to-final rule implementing changes to MDR. The agency is withdrawing the rule because of adverse comments ("The Gray Sheet" Aug. 10, p. 7)
You may also be interested in...
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.
The Trump administration says a COVID-19 vaccine could be available in as little as 12 months, but most experts think that is overpromising unless safety or efficacy standards are sacrificed. Many are urging pivotal studies that look at clinical outcomes, not surrogates, for US FDA approval.
When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.